Young Chan Kim

Dr Young Chan Kim is Sir Henry Wellcome Fellow, Principal Investigator at the Oxford Vaccine Group, and Director of Graduate Studies in the Department of Paediatrics at the University of Oxford, and Research Fellow at Wolfson College. A clinician-scientist trained at Imperial College London (BSc in Biochemistry), the University of Nottingham (BMBS, BMedSci and MRes), and Oxford, he completed his DPhil in Clinical Medicine on vaccine development against arthropod-borne viruses and was awarded the Nuffield Department of Medicine Graduate Student Prize as Overall Winner. His research spans translational vaccinology, controlled human infection models, and the discovery of immune correlates of protection to accelerate vaccines for neglected and emerging infectious diseases. He has led or contributed to vaccine programmes in enteric fever, plague, Q fever, chikungunya/Mayaro, and Chagas disease, building pathways from antigen design to experimental medicine and clinical translation. Dr Kim’s work combines scientific innovation with global health impact, with a particular focus on vaccine strategies that are scalable, deployable, and relevant to populations most affected by infectious disease.